Infant flu protection from maternal vaccination varied by timing, while pediatric vaccination fell to 49.4%, experts report at IDWeek 2026.
|Articles|April 26, 2011
COMING SOON...
Our coverage from the Academy of Managed Care Pharmacy's 23rd Annual Meeting & Showcase.
Advertisement
Coverage from the Academy of Managed Care Pharmacy’s 23rd Annual Meeting & Showcase. Our reporting from the conference will include video interviews with thought leaders and coverage of special healthcare reform implementation issues, payment reform, care delivery, coverage requirements, comparative effectiveness research, and more.
Don’t miss our as-they-happen highlights from the nation’s premier event regarding managed care pharmacy.
Advertisement
Related to this article
Speakers at IDWeek 2026 urged shifting global health partnerships from donor-recipient models to shared, locally led ownership as funding contracts.
ALIS added to azithromycin and ethambutol raised culture conversion in new MAC lung disease, with rare resistance, in an ENCORE analysis at IDWeek 2026.
AMCP Nexus 2026 brings managed care leaders to San Diego October 26-29 to tackle Medicare negotiation, drug pricing policy, AI, and patient access.
IDWeek 2026 posters describe a rule-based tool classifying about 1 in 5 patients with cUTI as outpatient-eligible and 5 clusters with varied LOS.
Insmed’s once-daily TPIP prodrug shows sustained lung vasodilation in PAH and PH-ILD, improving walk distance and other key measures.
ASPEN links green sputum to neutrophils and exacerbations; brensocatib (DPP1) lowers purulence, while meta-analysis supports fewer flare-ups in bronchiectasis.
At CHEST 2026, 3 speakers explained why respiratory medications stay expensive, assessed what recent federal, state, and industry fixes have achieved, and urged clinicians to use their voices on behalf of patients.
Advertisement
Advertisement
Trending on AJMC
1
Extension Studies in TPIP Show Promise in PAH, PH-ILD
2
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
3
Inhaled Amikacin Raises Culture Conversion in New MAC Lung Disease
4
Bronchiectasis GWAS Highlights Candidate Targets Shared With COPD
5